Review
Immunology and Cell Biology (2007) 85, 46–54. doi:10.1038/sj.icb.7100013; published online 5 December 2006
The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection
Anthony A Scalzo1,2, Alexandra J Corbett1,2, William D Rawlinson3, Gillian M Scott4 and Mariapia A Degli-Esposti1,2
- 1Immunology and Virology Program, Centre for Ophthalmology and Visual Science, The University of Western Australia, Nedlands, Western Australia, Australia
- 2Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia
- 3Department of Microbiology, Virology Division, SEALS, Prince of Wales Hospital, Randwick, New South Wales, Australia
- 4Virology Research, POWH and UNSW Research Laboratories, Prince of Wales Hospital, Randwick, New South Wales, Australia
Correspondence: Dr AA Scalzo, Centre for Experimental Immunology, Lions Eye Institute, 2 Verdun St, Nedlands, Western Australia 6009, Australia. E-mail: scals@cyllene.uwa.edu.au
Received 9 October 2006; Accepted 12 October 2006; Published online 5 December 2006.
Abstract
Cytomegalovirus (CMV) remains a major human pathogen causing significant morbidity and mortality in immunosuppressed or immunoimmature individuals. Although significant advances have been made in dissecting out certain features of the host response to human CMV (HCMV) infection, the strict species specificity of CMVs means that most aspects of antiviral immunity are best assessed in animal models. The mouse model of murine CMV (MCMV) infection is an important tool for analysis of in vivo features of host–virus interactions and responses to antiviral drugs that are difficult to assess in humans. Important studies of the contribution of host resistance genes to infection outcome, interplays between innate and adaptive host immune responses, the contribution of virus immune evasion genes and genetic variation in these genes to the establishment of persistence and in vivo studies of resistance to antiviral drugs have benefited from the well-developed MCMV model. In this review, we discuss recent advances in the immunobiology of host–CMV interactions that provide intriguing insights into the complex interplay between host and virus that ultimately facilitates viral persistence. We also discuss recent studies of genetic responses to antiviral therapy, particularly changes in DNA polymerase and protein kinase genes of MCMV and HCMV.
Keywords:
viral infection, genetic variability, immune evasion, cytomegalovirus, NK cells, CTL
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Cytomegalovirus: from evasion to suppression?Nature Immunology News and Views (01 Nov 2001)
Clever, cleverer, cleverestNature Immunology News and Views (01 Jun 2002)
See all 5 matches for News And ViewsRESEARCH
MCMV glycoprotein gp40 confers virus resistance to CD8 + T cells and NK cells in vivoNature Immunology Article (01 Jun 2002)
A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surfaceThe EMBO Journal Article (15 Feb 1997)
See all 22 matches for Research
